back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-04-04 16:20 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$27,149
+4,429 vol $6.13 each |
54,649 | |
| Filed 2023-01-04 15:21 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$26,098
+2,730 vol $9.56 each |
50,220 | |
| Filed 2022-12-16 15:56 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$231,235
+22,872 vol $10.11 each |
47,490 | |
| Filed 2022-10-05 15:57 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$25,534
+2,869 vol $8.90 each |
24,618 | |
| Filed 2022-07-05 15:03 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$25,200
+2,016 vol $12.50 each |
21,749 | |
| Filed 2022-01-11 15:39 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$27,557
+1,825 vol $15.10 each |
17,890 | |
| Filed 2022-01-11 15:34 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$26,870
+1,478 vol $18.18 each |
1,478 | |
| Filed 2021-12-13 16:38 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$14,071
+774 vol $18.18 each |
||
| Filed 2021-12-13 16:41 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$217,054
+14,587 vol $14.88 each |
15,361 | |
| Filed 2021-12-13 16:38 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$14,071
+774 vol $18.18 each |
774 | |
| Filed 2021-12-13 16:34 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 12:24 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$186,720
+12,000 vol $15.56 each |
94,004 | |
| Filed 2019-06-11 10:36 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$229,720
+14,773 vol $15.55 each |
82,004 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,163
+10,811 vol $8.34 each |
67,231 | |
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Lanthier, John Spencer
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
56,420 |